Pathways of cellular proteostasis in aging and disease
- PMID: 29127110
- PMCID: PMC5748993
- DOI: 10.1083/jcb.201709072
Pathways of cellular proteostasis in aging and disease
Abstract
Ensuring cellular protein homeostasis, or proteostasis, requires precise control of protein synthesis, folding, conformational maintenance, and degradation. A complex and adaptive proteostasis network coordinates these processes with molecular chaperones of different classes and their regulators functioning as major players. This network serves to ensure that cells have the proteins they need while minimizing misfolding or aggregation events that are hallmarks of age-associated proteinopathies, including neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. It is now clear that the capacity of cells to maintain proteostasis undergoes a decline during aging, rendering the organism susceptible to these pathologies. Here we discuss the major proteostasis pathways in light of recent research suggesting that their age-dependent failure can both contribute to and result from disease. We consider different strategies to modulate proteostasis capacity, which may help develop urgently needed therapies for neurodegeneration and other age-dependent pathologies.
© 2018 Klaips et al.
Figures




Similar articles
-
Lipid Assemblies at the Crossroads of Aging, Proteostasis, and Neurodegeneration.Trends Cell Biol. 2019 Dec;29(12):954-963. doi: 10.1016/j.tcb.2019.09.003. Epub 2019 Oct 25. Trends Cell Biol. 2019. PMID: 31669295 Review.
-
Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.Biofactors. 2017 Nov;43(6):737-759. doi: 10.1002/biof.1264. Epub 2016 Feb 22. Biofactors. 2017. PMID: 26899445 Review.
-
The Nucleolus as a Proteostasis Regulator.Trends Cell Biol. 2019 Nov;29(11):849-851. doi: 10.1016/j.tcb.2019.08.002. Epub 2019 Aug 28. Trends Cell Biol. 2019. PMID: 31473054
-
Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.Neurochem Int. 2021 May;145:105011. doi: 10.1016/j.neuint.2021.105011. Epub 2021 Mar 10. Neurochem Int. 2021. PMID: 33711400 Review.
-
Carrying Excess Baggage Can Slowdown Life: Protein Clearance Machineries That Go Awry During Aging and the Relevance of Maintaining Them.Mol Neurobiol. 2022 Feb;59(2):821-840. doi: 10.1007/s12035-021-02640-2. Epub 2021 Nov 18. Mol Neurobiol. 2022. PMID: 34792731 Review.
Cited by
-
Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.Acta Neuropathol Commun. 2021 Apr 8;9(1):65. doi: 10.1186/s40478-021-01159-w. Acta Neuropathol Commun. 2021. PMID: 33832539 Free PMC article.
-
Secretion of pro-oncogenic AGR2 protein in cancer.Heliyon. 2020 Sep 23;6(9):e05000. doi: 10.1016/j.heliyon.2020.e05000. eCollection 2020 Sep. Heliyon. 2020. PMID: 33005802 Free PMC article. Review.
-
The ribosome-associated chaperone Zuo1 controls translation upon TORC1 inhibition.EMBO J. 2023 Dec 11;42(24):e113240. doi: 10.15252/embj.2022113240. Epub 2023 Nov 20. EMBO J. 2023. PMID: 37984430 Free PMC article.
-
The Hidden Dangers of Sedentary Living: Insights into Molecular, Cellular, and Systemic Mechanisms.Int J Mol Sci. 2024 Oct 6;25(19):10757. doi: 10.3390/ijms251910757. Int J Mol Sci. 2024. PMID: 39409085 Free PMC article. Review.
-
Derailed protein turnover in the aging mammalian brain.Mol Syst Biol. 2024 Feb;20(2):120-139. doi: 10.1038/s44320-023-00009-2. Epub 2024 Jan 5. Mol Syst Biol. 2024. PMID: 38182797 Free PMC article.
References
-
- Agashe V.R., Guha S., Chang H.C., Genevaux P., Hayer-Hartl M., Stemp M., Georgopoulos C., Hartl F.U., and Barral J.M.. 2004. Function of trigger factor and DnaK in multidomain protein folding: increase in yield at the expense of folding speed. Cell. 117:199–209. 10.1016/S0092-8674(04)00299-5 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical